The Patent Finder

CASI Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents CASI Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 3 of 3 · Back to CASI Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,399,440Disease modifying anti-arthritic activity of 2-methoxyestradiol
Lapsed on the fee record
Ended Mar 19, 2025 · USPTO record
Lapsed on the fee recordEnded Mar 19, 2025USPTO record
US 7,087,592Compositions comprising purified 2-methoxyestradiol and methods of producing same
Term ended
Term ended Mar 12, 2022 · USPTO record
Term endedTerm ended Mar 12, 2022USPTO record
US 7,235,540Methods of using 2-methoxyestradiol of high purity
Term ended
Ended no later than Aug 23, 2020 · USPTO record
Term endedEnded no later than Aug 23, 2020USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited